United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-640_210a82b7-8b08-42e6-8a9f-da481485dd4f
- Product NDC
- 71610-640
- Form
- TABLET
- Composition / generic term
- Buspirone Hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140825
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71610-640-30) · 71610-640-30
- 90 TABLET in 1 BOTTLE (71610-640-60) · 71610-640-60
- 180 TABLET in 1 BOTTLE (71610-640-80) · 71610-640-80
- 270 TABLET in 1 BOTTLE (71610-640-92) · 71610-640-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →